280 related articles for article (PubMed ID: 6295405)
1. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
Beretz A; Stierle A; Anton R; Cazenave JP
Biochem Pharmacol; 1982 Nov; 31(22):3597-600. PubMed ID: 6295405
[TBL] [Abstract][Full Text] [Related]
2. Prostacyclin potentiates 13-azaprostanoic acid-induced platelet deaggregation.
Parise LV; Venton DL; Le Breton GC
Thromb Res; 1982 Dec; 28(6):721-30. PubMed ID: 6301090
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin.
Mardla V; Kobzar G; Samel N
Platelets; 2004 Aug; 15(5):319-24. PubMed ID: 15370103
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of aggregation and secretion of human platelets by quercetin and other flavonoids: structure-activity relationships.
Beretz A; Cazenave JP; Anton R
Agents Actions; 1982 Jul; 12(3):382-7. PubMed ID: 6182778
[TBL] [Abstract][Full Text] [Related]
5. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
Hawiger J; Parkinson S; Timmons S
Nature; 1980 Jan; 283(5743):195-7. PubMed ID: 6985716
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human platelet cyclic AMP phosphodiesterase and of platelet aggregation by a hemisynthetic flavonoid, amentoflavone hexaacetate.
Beretz A; Briançon-Scheid F; Stierlé A; Corre G; Anton R; Cazenave JP
Biochem Pharmacol; 1986 Jan; 35(2):257-62. PubMed ID: 3002388
[TBL] [Abstract][Full Text] [Related]
7. Sub-aggregatory doses of catecholamines prevent prostacyclin-induced inhibition of platelet aggregation.
Buttrick PM; Forscher CA; Sussman II; Mueller HS
Am Heart J; 1985 Jun; 109(6):1258-63. PubMed ID: 2988323
[TBL] [Abstract][Full Text] [Related]
8. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of platelet aggregation and elevation of cyclic-AMP levels in platelets by 13,14-dehydro PGI2 methyl ester.
Malmsten C; Claesson HE; Fried J
Prostaglandins Med; 1980 Jun; 4(6):453-63. PubMed ID: 6251494
[TBL] [Abstract][Full Text] [Related]
10. Prostacyclin analogs: antiaggregatory potency and enhancement of cAMP levels in human platelet rich plasma.
Dembinska-Kiec A; Rücker W; Schönhöfer PS; Gandolfi C
Thromb Haemost; 1979 Dec; 42(4):1340-3. PubMed ID: 232318
[No Abstract] [Full Text] [Related]
11. Reduced platelet aggregation by effects of pentoxifylline on vascular prostacyclin isomerase and platelet cyclic AMP.
Weithmann KU
Gen Pharmacol; 1983; 14(1):161-2. PubMed ID: 6298055
[TBL] [Abstract][Full Text] [Related]
12. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
Reele SB; Miller OV; Spillers C; Gorman RR
Prostaglandins; 1983 Aug; 26(2):287-302. PubMed ID: 6316420
[TBL] [Abstract][Full Text] [Related]
13. The influence of epinephrine on prostacyclin (PGI2) induced dissociation of ADP aggregated plateletes.
Rao GH; Reddy KR; White JG
Prostaglandins Med; 1980 Jun; 4(6):385-97. PubMed ID: 6251492
[TBL] [Abstract][Full Text] [Related]
14. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
Fisher CA; Kappa JR; Sinha AK; Cottrell ED; Reiser HJ; Addonizio VP
J Lab Clin Med; 1987 Feb; 109(2):184-90. PubMed ID: 2433373
[TBL] [Abstract][Full Text] [Related]
15. Is prostacyclin a physiologically important circulating anti-platelet agent?
Steer ML; MacIntyre DE; Levine L; Salzman EW
Nature; 1980 Jan; 283(5743):194-5. PubMed ID: 6243178
[No Abstract] [Full Text] [Related]
16. In vitro effects of ethanol on rabbit platelet aggregation, secretion of granule contents, and cyclic AMP levels in the presence of prostacyclin.
Rand ML; Gross PL; Jakowec DM; Packham MA; Mustard JF
Thromb Haemost; 1989 Apr; 61(2):254-8. PubMed ID: 2546284
[TBL] [Abstract][Full Text] [Related]
17. Synergistic inhibition of platelet activation by plasmin and prostaglandin I2.
Schafer AI; Zavoico GB; Loscalzo J; Maas AK
Blood; 1987 May; 69(5):1504-7. PubMed ID: 3032310
[TBL] [Abstract][Full Text] [Related]
18. Interaction of prostaglandins with adenosine diphosphate induced increase in cytosolic free calcium in human platelets.
Ohman KP; Yun JC; Keiser HR
Scand J Clin Lab Invest; 1992 Oct; 52(6):483-90. PubMed ID: 1329185
[TBL] [Abstract][Full Text] [Related]
19. Heparin neutralization of PGI2: effects upon platelets.
Saba HI; Saba SR; Blackburn CA; Hartmann RC; Mason RG
Science; 1979 Aug; 205(4405):499-501. PubMed ID: 377493
[TBL] [Abstract][Full Text] [Related]
20. Drug stimulated prostacyclin release.
Weithmann KU
Ric Clin Lab; 1981; 11 Suppl 1():209-14. PubMed ID: 6324324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
